News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,767 Results
Type
Article (87023)
Company Profile (704)
Press Release (767030)
Multimedia
Podcasts (154)
Webinars (20)
Section
Business (232895)
Career Advice (4133)
Deals (39769)
Drug Delivery (130)
Drug Development (91141)
Employer Resources (199)
FDA (18212)
Job Trends (17374)
News (396991)
Policy (39847)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (110)
Alliances (56978)
ALS (123)
Alzheimer's disease (1616)
Antibody-drug conjugate (ADC) (192)
Approvals (18168)
Artificial intelligence (418)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (105)
Brain cancer (43)
Breast cancer (411)
Cancer (3248)
Cardiovascular disease (260)
Career advice (3542)
Career pathing (34)
CAR-T (217)
CDC (43)
Cell therapy (598)
Cervical cancer (25)
Clinical research (74538)
Collaboration (1165)
Company closure (3)
Compensation (762)
Complete response letters (42)
COVID-19 (2917)
CRISPR (71)
C-suite (404)
Cystic fibrosis (125)
Data (3303)
Decentralized trials (2)
Denatured (55)
Depression (83)
Diabetes (388)
Diagnostics (7002)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (194)
Drug pricing (160)
Drug shortages (36)
Duchenne muscular dystrophy (166)
Earnings (98088)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131694)
Executive appointments (930)
FDA (20180)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1047)
Gene editing (154)
Generative AI (42)
Gene therapy (466)
GLP-1 (957)
Government (5296)
Grass and pollen (7)
Guidances (281)
Healthcare (20921)
HIV (46)
Huntington's disease (32)
IgA nephropathy (46)
Immunology and inflammation (195)
Immuno-oncology (15)
Indications (43)
Infectious disease (3123)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (131)
Interviews (813)
IPO (17907)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (62)
Layoffs (607)
Leadership (27)
Legal (10139)
Liver cancer (87)
Longevity (12)
Lung cancer (452)
Lymphoma (230)
Machine learning (14)
Management (65)
Manufacturing (487)
MASH (105)
Medical device (14760)
Medtech (14770)
Mergers & acquisitions (22626)
Metabolic disorders (991)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (165)
Neuropsychiatric disorders (47)
Neuroscience (2416)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (503)
Opinion (295)
Ovarian cancer (108)
Pain (131)
Pancreatic cancer (136)
Parkinson's disease (206)
Partnered (25)
Patents (343)
Patient recruitment (197)
Peanut (55)
People (65832)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22995)
Phase II (32367)
Phase III (24371)
Pipeline (1910)
Policy (259)
Postmarket research (3554)
Preclinical (10389)
Press Release (72)
Prostate cancer (157)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (548)
Real estate (7402)
Recruiting (76)
Regulatory (27360)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (106)
Series A (175)
Series B (124)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (74)
The Weekly (97)
Vaccines (949)
Venture capital (62)
Weight loss (341)
Women's health (52)
Worklife (20)
Date
Today (198)
Last 7 days (674)
Last 30 days (2326)
Last 365 days (33802)
2025 (20306)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (72)
Alaska (7)
Arizona (283)
Arkansas (14)
Asia (50621)
Australia (8895)
California (8167)
Canada (2507)
China (757)
Colorado (347)
Connecticut (364)
Delaware (218)
Europe (116205)
Florida (1218)
Georgia (278)
Hawaii (3)
Idaho (67)
Illinois (761)
India (34)
Indiana (404)
Iowa (19)
Japan (248)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (73)
Maryland (1152)
Massachusetts (6253)
Michigan (281)
Minnesota (510)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (87)
New Hampshire (74)
New Jersey (2278)
New Mexico (31)
New York (2260)
North Carolina (1281)
North Dakota (10)
Northern California (3563)
Ohio (263)
Oklahoma (17)
Oregon (48)
Pennsylvania (1744)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (3050)
Tennessee (134)
Texas (1260)
United States (30717)
Utah (240)
Virginia (223)
Washington D.C. (80)
Washington State (713)
West Virginia (4)
Wisconsin (89)
There are 854,767 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow
August 7, 2025
·
5 min read
Press Releases
Alkeus Pharmaceuticals Announces Presentation of Positive Interim TEASE-3 Study Data in Early-Stage Stargardt Disease Patients Treated with Oral Gildeuretinol
August 7, 2025
·
4 min read
Press Releases
Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 7, 2025
·
8 min read
Press Releases
Kedrion receives FDA Orphan Drug Designation for investigational plasma-derived treatment for Congenital Aceruloplasminemia
August 7, 2025
·
4 min read
Press Releases
Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 7, 2025
·
9 min read
Press Releases
Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results
August 7, 2025
·
1 min read
Press Releases
Dogwood Therapeutics Announces Enrollment of First Fifty Patients in Ongoing Halneuron® Phase 2b Trial
August 7, 2025
·
5 min read
Press Releases
ProteinQure Receives Regulatory Clearance to Initiate Phase I Trial for PQ203 in the U.S. and Canada; Granted FDA Fast Track Designation
August 7, 2025
·
1 min read
Press Releases
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
August 7, 2025
·
14 min read
Mergers & acquisitions
Novartis Continues Hunt for New Assets With Rumored Takeover of RNA Specialist Avidity
There is no certainty that the buyout will come to pass, according to
The Financial Times
, which first reported the rumors.
August 7, 2025
·
2 min read
·
Tristan Manalac
1 of 85,477
Next
